Filing Details
- Accession Number:
- 0001317757-10-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-23 16:29:20
- Reporting Period:
- 2010-08-20
- Filing Date:
- 2010-08-23
- Accepted Time:
- 2010-08-23 16:29:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
792977 | Amag Pharmaceuticals Inc. | AMAG | In Vitro & In Vivo Diagnostic Substances (2835) | 042742593 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1408474 | Phd Md F Lee Allen | C/O Amag Pharmaceuticals, Inc. 100 Hayden Avenue Lexington MA 02421 | Chief Medical Officer And Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-08-20 | 13,750 | $0.00 | 1,912 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading pan adopted by the reporting person.
- The shares sold on this date were sold in multiple transactions. The price is the weighted average sales price per share of all shares sold on this day. The actual sales prices range from $27.878-$28.71. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.